U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H23NO2
Molecular Weight 273.37
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TILIDINE

SMILES

CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2

InChI

InChIKey=WDEFBBTXULIOBB-WBVHZDCISA-N
InChI=1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3/t15-,17+/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H23NO2
Molecular Weight 273.37
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 14:59:30 UTC 2023
Edited
by admin
on Fri Dec 15 14:59:30 UTC 2023
Record UNII
GY33N31E9Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TILIDINE
INN   MI   WHO-DD  
INN  
Official Name English
3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(DIMETHYLAMINO)-1-PHENYL-, ETHYL ESTER, (TRANS)-(±)-
Common Name English
TILIDATE
Common Name English
TILIDINE [MI]
Common Name English
TRANS-TILIDINE
Common Name English
DL-TRANS-TILIDINE
Common Name English
3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(DIMETHYLAMINO)-1-PHENYL-, ETHYL ESTER, (1R,2S)-REL-
Systematic Name English
tilidine [INN]
Common Name English
IDS-NT-003
Code English
Tilidine [WHO-DD]
Common Name English
(±)-ETHYL TRANS-2-(DIMETHYLAMINO)-1-PHENYL-3-CYCLOHEXENE-1-CARBOXYLATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
WHO-VATC QN02AX01
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
NCI_THESAURUS C241
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
DEA NO. 9750
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
WHO-ATC N02AX01
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
Code System Code Type Description
DRUG CENTRAL
2663
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
DRUG BANK
DB13787
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
MESH
D013993
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
ECHA (EC/EINECS)
243-774-7
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
ALTERNATIVE
RXCUI
10597
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY RxNorm
FDA UNII
GY33N31E9Y
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
MERCK INDEX
m10864
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
257-522-9
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
SMS_ID
100000082696
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
WIKIPEDIA
TILIDINE
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
CAS
20380-58-9
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
SUPERSEDED
CAS
51931-66-9
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
NCI_THESAURUS
C152628
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
EVMPD
SUB11051MIG
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
INN
2510
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
CHEBI
77823
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
ChEMBL
CHEMBL2220384
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
PUBCHEM
30131
Created by admin on Fri Dec 15 14:59:30 UTC 2023 , Edited by admin on Fri Dec 15 14:59:30 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
TARGET->WEAK AGONIST
Inhibition of forskolin-induced cAMP accumulation
IC50
ACTIVE ENANTIOMER->RACEMATE
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
METABOLITE ACTIVE -> PRODRUG
After oral intake tilidine is completely absorbed and rapidly metabolised to nortilidine, bisnortilidine. 100 fold more active than Tilidine.
Related Record Type Details
ACTIVE MOIETY